Breaking News Instant updates and real-time market news.

APC

Anadarko

$56.39

0.9 (1.62%)

, RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

12:41
11/17/18
11/17
12:41
11/17/18
12:41

Investors may find bargains among oil, natural gas stocks, Barron's says

Investors have been shaken by concerns that demand for oil and natural gas will weaken, but those worries may be overblown and the shares of many energy companies look attractive after a recent 15% retreat in the sector, Andrew Bary writes in this week's edition of Barron's. Investors may want to consider BP (BP), Chevron (CVX), ExxonMobil (XOM), Royal Dutch Shell (RDS.A), Anadarko Petroleum (APC), EOG Resources (EOG), Occidental Petroleum (OXY), Cabot Oil & Gas (COG), EQT (EQT), Halliburton (HAL) and Schlumberger (SLB), he contends. Reference Link

APC

Anadarko

$56.39

0.9 (1.62%)

RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

RDS.A

Royal Dutch Shell

$62.02

0.34 (0.55%)

XOM

Exxon Mobil

$78.99

0.81 (1.04%)

CVX

Chevron

$119.14

2.18 (1.86%)

BP

BP

$40.85

-0.3 (-0.73%)

EOG

EOG Resources

$105.21

3.57 (3.51%)

OXY

Occidental Petroleum

$73.32

0.71 (0.98%)

COG

Cabot Oil & Gas

$25.73

0.09 (0.35%)

EQT

EQT Corporation

$16.62

-0.55 (-3.20%)

HAL

Halliburton

$32.46

0.02 (0.06%)

SLB

Schlumberger

$48.24

0.17 (0.35%)

  • 26

    Nov

  • 18

    Jan

  • 22

    Jan

APC Anadarko
$56.39

0.9 (1.62%)

11/16/18
JPMS
11/16/18
NO CHANGE
JPMS
Overweight
Anadarko strategic update a 'strong positive,' says JPMorgan
JPMorgan analyst Arun Jayaram views Anadarko Petroleum's strategic update last night for the company's 2019 capital plan and shareholder enhancement initiatives as a "strong positive." The midpoint of Anadarko's capital expenditure guidance sits 14% below the Street and only 1% below on total oil volumes, Jayaram tells investors in a research note. The company also announced a $1B increase in its buyback, 20% increase in the quarterly dividend, and $500M of incremental debt-reduction, the analyst points out. He expects the stock to trade higher today and keeps an Overweight rating on Anadarko.
11/08/18
SBSH
11/08/18
NO CHANGE
SBSH
Citi closes Catalyst Watches after Colorado votes down Proposition 112
Colorado's Proposition 112 failed to garner a majority vote required to pass, coming in with 43% "yes" votes based on the most recently updated results, Citi analyst Robert Morris tells investors in a research note. The analyst closed Catalyst Watches on Anadarko (APC), Noble Energy (NBL), SRC Energy (SRCI) and Extraction Oil & Gas (XOG) after voters dismissed the drilling ban. He expects "regulatory risks to continue to simmer on the back burner."
11/13/18
STFL
11/13/18
NO CHANGE
STFL
Niobrara-focused E&Ps pricing in 'political disaster,' says Stifel
Stifel analyst Michael Scialla noted that the stocks of Exploration & Production companies with significant exposure to Colorado's Niobrara play rebounded following the defeat of Proposition 112, but have since faded and underperformed the broader group as rhetoric from a Democrat-controlled Colorado legislature has investors more concerned about the state's political climate than they were prior to the vote. While he believes greater local control of oil and gas operations in Colorado is "inevitable," Scialla said he does not anticipate significant drilling inventory reductions or cost increases. He looks for Anadarko (APC), Bonanza Creek (BCEI), HighPoint Resources (HPR), Noble Energy (NBL), PDC Energy (PDCE), SRC Energy (SRCI) and Extraction Oil & Gas (XOG) and several private companies to proactively seek a solution to prevent another initiative like Prop. 112 from reaching the 2020 ballot, Scialla tells investors. He views shares of Anadarko, HighPoint, Noble, PDC and SRC as undervalued and maintains Buy ratings on those five stocks.
11/16/18
MUFG
11/16/18
NO CHANGE
Target $92
MUFG
Overweight
Anadarko price target lowered to $92 from $100 at MUFG
MUFG analyst Michael McAllister lowered his price target for Anadarko Petroleum to $92 after the company revealed its 2019 capital plan and production guidance. To recognize the recent action in the crude oil markets, the analyst lowered his price realization estimates by 7% for 2019 and 2020. Further, he points out that the 20% increase in his capital expenditure assumptions also has a negative effect on financial metrics. McAllister, however, reaffirms an Overweight rating on Anadarko.
RDS.B Royal Dutch Shell
$63.97

0.19 (0.30%)

08/31/18
08/31/18
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. BP (BP) and Royal Dutch Shell (RDS.A) were upgraded to Hold from Underperform at Santander. 2. Dollar Tree (DLTR) downgraded to Market Perform from Outperform at Telsey Advisory. 3. Electronic Arts (EA) and Activision Blizzard (ATVI) were downgraded to Neutral from Buy at BofA/Merrill. 4. Gain Capital (GCAP) initiated with a Neutral at JPMorgan. 5. Avaya (AVYA) initiated with a Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RDS.A Royal Dutch Shell
$62.02

0.34 (0.55%)

09/11/18
BREN
09/11/18
INITIATION
BREN
Hold
Royal Dutch Shell initiated with a Hold at Berenberg
Berenberg analyst Henry Tarr started Royal Dutch Shell with a Hold rating and EUR 31 price target.
09/28/18
STFL
09/28/18
NO CHANGE
Target $5
STFL
Buy
Stifel reiterates Buy on Civeo as Shell seems close to starting LNG project
Noting that several reports over the last few days indicate a positive decision about a Shell-led (RDS.A) LNG project in Western Canada could be announced as soon as next week, Stifel analyst Stephen Gengaro reiterated his Buy rating and $5 price target on shares of Civeo (CVEO), for whom he has previously said the Shell project could be a "game-changer." If the LNG project receives a positive final investment decision, he believes Civeo will benefit via its ownership of Sitka Lodge, its 40% owned joint venture with Bird Construction and the potential for a long-term project for Civeo to provide ancillary services, said Gengaro.
10/03/18
REDB
10/03/18
UPGRADE
REDB
Neutral
Royal Dutch Shell upgraded to Neutral from Sell at Redburn
Redburn analyst Rob West upgraded BP to Neutral from Sell citing value creation in the LNG segment.
10/22/18
SIMM
10/22/18
INITIATION
Target $72
SIMM
Neutral
Royal Dutch Shell assumed with a Neutral at Simmons
Simmons analyst Blake Fernandez assumed Royal Dutch Shell with a Neutral rating and a price target of $72 as part of his broader research note on Integrated Oils, suggesting that the industry stands to benefit from the current stage of the energy cycle. Fernandez notes that the company enjoyed stronger than expected earnings last year, but its past couple of quarters have been underwhelming because of "multiple transitory culprits driving results including tax, derivatives, etc." The analyst prefers to wait for a reversal of this trend before becoming more constructive on the stock.
XOM Exxon Mobil
$78.99

0.81 (1.04%)

09/28/18
OPCO
09/28/18
NO CHANGE
Target $89
OPCO
Outperform
Teladoc price target raised to $89 from $68 at Oppenheimer
Oppenheimer analyst Mohan Naidu reiterated an Outperform rating on Teledoc and raised his price target to $89 from $68 following the company's analyst day, which highlighted its new deal flow, including relationships with Centene (CNC) and Exxon (XOM), and a very strong pipeline. The recent CMS telehealth proposal makes Medicare a 2020 tailwind, Naidu tells investors in a research note, and says he has gained confidence that Teladoc's competitive barriers include its broad platform and its network of physicians that quickly matches supply and demand.
09/11/18
BREN
09/11/18
INITIATION
Target $84
BREN
Hold
Exxon Mobil initiated with a Hold at Berenberg
Berenberg analyst Henry Tarr started Exxon Mobil with a Hold rating and $84 price target.
09/21/18
RBCM
09/21/18
NO CHANGE
Target $115
RBCM
Outperform
Exxon Mobil long term investment visibility improving, says RBC Capital
RBC Capital analyst Biraj Borkhataria kept his Outperform rating and $115 price target on Exxon Mobil after meeting with its investor relations VP at the company's recent non deal roadshow. The analyst notes that the discussions focused on Exxon Mobil's accelerating rig activity in the Permian and Guyana with little impact observed from wider differentials. Borkhataria also believes that stock buybacks may begin as soon as early 2019, ahead of expectations, adding that the Exxon Mobil stock remains one of his "top ideas for longer term".
10/22/18
SIMM
10/22/18
INITIATION
Target $92
SIMM
Neutral
Exxon Mobil assumed with a Neutral at Simmons
Simmons analyst Blake Fernandez assumed Exxon Mobil with a Neutral rating and a price target of $92 as part of his broader research note on Integrated Oils, suggesting that the industry stands to benefit from the current stage of the energy cycle. Fernandez notes that the current price point may be a "highly attractive" entry for medium to long term investors, but adds that his Neutral stance is a function of where the company is in its investment cycle. The analyst adds that Exxon Mobil's planning of "accelerated spending" has led to a contraction in its free cash flow yield.
CVX Chevron
$119.14

2.18 (1.86%)

11/05/18
FBCO
11/05/18
UPGRADE
FBCO
Outperform
Chevron upgraded to Outperform from Neutral at Credit Suisse
11/05/18
11/05/18
UPGRADE
Target $138

Outperform
Chevron upgraded to Outperform on continued execution at Credit Suisse
As previously reported, Credit Suisse analyst William Featherston upgraded Chevron to Outperform from Neutral, with a $138 price target, citing continued execution, free cash flow visibility and compelling valuation. The analyst believes the company continues to execute on its already superior growth outlook, which should translate into better than expected capital efficiencies into 2019 and sets up for continued robust free cash flow. He sees upside to 2019-2020 volume forecasts supported by strong Permian growth, driving an estimated about $10B-$11B per annum of surplus free cash flow generation, which should enable Chevron to sustain competitive dividend growth and expand the scope of its current share buyback program.
10/22/18
SIMM
10/22/18
INITIATION
Target $139
SIMM
Overweight
Chevron assumed with an Overweight at Simmons
Simmons analyst Blake Fernandez assumed Chevron with an Overweight rating and a price target of $139 as part of his broader research note on Integrated Oils, suggesting that the industry stands to benefit from the current stage of the energy cycle. Fernandez adds that Chevron is his Top Idea given that it had the worst year-to-date equity performance in the peer group and expects the stock to "play catch-up". The analyst further points to the company's "ample Permian takeaway capacity" as alleviation of "industry bottlenecks next year could prompt fund rotation back into equities with leverage" to the region.
10/03/18
REDB
10/03/18
DOWNGRADE
REDB
Neutral
Chevron downgraded to Neutral from Buy at Redburn
Redburn analyst Rob West downgraded Chevron to Neutral from Buy with a $115 fair value, down from $130 saying it benefits less from tightness in gas and increasing late cycle risks.
BP BP
$40.85

-0.3 (-0.73%)

10/03/18
REDB
10/03/18
UPGRADE
REDB
Buy
BP upgraded to Buy from Neutral at Redburn
Redburn analyst Rob West upgraded BP to Buy from Neutral and maintained a $90 fair value estimate to reflect increasing free cash flow from ramping global gas mega-projects and hidden value from divestment programs.
09/05/18
09/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Anthem (ANTM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Zack Sopcak saying he contends that the disruption in the pharmacy benefits management landscape via M&A and government-led drug pricing reform positions Anthem for underappreciated share gain and accelerated profit growth. 2. BP (BP) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. GasLog (GLOG) upgraded to Buy from Hold at DNB Markets. 4. CenterPoint Energy (CNP) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Turnure saying he sees an "attractive outlook for the proforma company" with 8.2% annual earnings growth through 2021 "under a conservative range of assumptions." 5. PerkinElmer (PKI) upgraded to Equal Weight from Underweight at Barclays with analyst Jack Meehan saying he is more positive on PerkinElmer's near-term growth prospects in Diagnostics due to its recent investments. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/22/18
SIMM
10/22/18
INITIATION
Target $52
SIMM
Overweight
BP assumed with an Overweight at Simmons
Simmons analyst Blake Fernandez assumed BP with a Overweight rating and a price target of $52 as part of his broader research note on Integrated Oils suggesting that the industry stands to benefit from the current stage of the energy cycle. The analyst cites an improving macro backdrop, increased deleveraging, and expanding shareholder returns that should produce relative outperformance for this assumed group. Fernandez points to BP's "peer leading" 11% expected free cash flow yield and anticipated buybacks coming from the decline of Macondo related payments starting later in 2018, adding that BP also has the most earnings sensitivity to oil price movements.
09/11/18
BREN
09/11/18
INITIATION
BREN
Buy
BP initiated with a Buy at Berenberg
Berenberg analyst Henry Tarr started BP with a Buy rating and 665p price target. The company is starting to grow again, the analyst contends.
EOG EOG Resources
$105.21

3.57 (3.51%)

11/16/18
FBCO
11/16/18
UPGRADE
Target $128
FBCO
Outperform
EOG Resources upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst William Featherston upgraded EOG Resources to Outperform from Neutral and maintained a $128 price target. In a research note to investors in which he calls EOG "arguably one of the best run E&P companies for a valuation near peers," Featherston says that while he acknowledges the sharp drop-off in Q4 completion activity poses a risk to 1Q19 volumes, he believes this is already well-flagged by the market with consensus forecasting 1Q19 oil production up just ~9 MBbld q/q. The analyst says shares now "finally" appear attractively priced.
11/16/18
FBCO
11/16/18
UPGRADE
FBCO
Outperform
EOG Resources upgraded to Outperform from Neutral at Credit Suisse
10/24/18
WELS
10/24/18
INITIATION
Target $154
WELS
Market Perform
EOG Resources resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Nitin Kumar resumed coverage of EOG Resources with a Market Perform rating and $154 price target. The analyst finds the current risk/reward in EOG relatively balanced at recent trading levels despite the premier asset portfolio and operational track record.
09/27/18
PIPR
09/27/18
INITIATION
PIPR
Overweight
EOG Resources assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Ryan Todd assumed coverage of EOG Resources with an Overweight rating and a $138 price target.
OXY Occidental Petroleum
$73.32

0.71 (0.98%)

11/12/18
LEHM
11/12/18
INITIATION
Target $84
LEHM
Overweight
Occidental Petroleum initiated with an Overweight at Barclays
Barclays analyst Paul Cheng started Occidental Petroleum with an Overweight rating and $84 price target. The company's "very clear line of sight" to delivering 8%-plus production growth and an 8%-plus free cash flow yield for years to come "will resonate with investors," Cheng tells investors in a research note.
11/07/18
EVER
11/07/18
UPGRADE
EVER
Outperform
Occidental Petroleum upgraded to Outperform from In Line at Evercore ISI
10/22/18
10/22/18
UPGRADE
Target $90

Strong Buy
Occidental Petroleum upgraded to Strong Buy on valuation at Raymond James
As previously reported, Raymond James upgraded Occidental Petroleum to Strong Buy from Outperform with a $90 price target. Analyst Pavel Molchanov said Occidental shares are down 2% year-to-date versus the E&P index's 8% gain, and the dividend yield now stands at 4.3%. The analyst believes this is an opportunistic time to upgrade shares given the firm's newly increased oil forecast.
10/22/18
RAJA
10/22/18
UPGRADE
RAJA
Strong Buy
Occidental Petroleum upgraded to Strong Buy from Outperform at Raymond James
COG Cabot Oil & Gas
$25.73

0.09 (0.35%)

11/15/18
11/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Blue Apron (APRN) downgraded to Neutral from Buy at Guggenheim with analyst Michael Graham saying the company's net loss of 71K customers was higher than anticipated even though EBITDA came in higher than expected. 2. Horizon Pharma (HZNP) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying after she spoke with management about planned investments in teprotumumab pre-launch and the Mirror trial, she reduced her 2019 forecasts for Krystexxa and Actimmune to below consensus. 3. Cabot Oil & Gas (COG) downgraded to Hold from Buy at Tudor Pickering. 4. Hawaiian Electric (HE) downgraded to Underperform from Neutral at BofA/Merrill with analyst Julien Dumoulin-Smith citing strong relative share performance on investor activism. 5. PG&E (PCG) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Stephen Byrd saying he sees an "unprecedented" level of uncertainty given that there is currently no liability cap that would be applied to 2018 wildfires. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/18
09/26/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cabot Oil & Gas (COG) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Devin McDermott saying U.S. natural gas should soon enter a new cycle of structural oversupply and stagnating demand. 2. Manhattan Associates (MANH) downgraded to Hold from Buy at SunTrust with analyst Terry Tillman saying while there was no change in his view of the company's fundamentals, the risk reward on the stock is much more balanced after it "outperformed significantly" since the last earnings report. 3. Lam Research (LRCX) downgraded to Neutral from Buy at UBS. 4. Paycom (PAYC) and Synchrony (SYF) were downgraded to Neutral from Buy at BofA/Merrill. 5. DowDuPont (DWDP) downgraded to Neutral from Buy at Nomura Instinet with analyst Aleksey Yefremov citing his commodity models based on recent changes in chemical prices and margins. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/15/18
TUDR
11/15/18
DOWNGRADE
TUDR
Hold
Cabot Oil & Gas downgraded to Hold from Buy at Tudor Pickering
10/23/18
WELS
10/23/18
DOWNGRADE
WELS
Market Perform
Cabot Oil & Gas downgraded to Market Perform from Outperform at Wells Fargo
EQT EQT Corporation
$16.62

-0.55 (-3.20%)

11/14/18
11/14/18
DOWNGRADE

Underweight
Morgan Stanley sees structural challenges at EQT, downgrades to Underweight
As previously reported, Morgan Stanley analyst Drew Venker downgraded EQT Corporation (EQT) to Underweight from Equal Weight, as he believes the market is missing EQT's high cost structure and declining production starting in 2020. Given the structural challenges he sees, Venker believes EQT's guidance appears optimistic and will be difficult to achieve, he tells investors. Based on his expectations for higher capex and lower production, his 2020 EBITDA estimate is 10% below what's implied by guidance, the analyst noted. Venker slashed his price target on EQT shares to $12 from $48, which also reflects the spin off of 80.1% of EQT's stake in Equitrans Midstream (ETRN) in November.
10/29/18
RBCM
10/29/18
NO CHANGE
Target $53
RBCM
Outperform
EQT Corporation price target lowered to $53 from $71 at RBC Capital
RBC Capital analyst Scott Hanold lowered his price target on EQT Corp to $53 to reflect the 40% decline in the company's stock price last week amid investor uncertainty regarding its new strategy. The analyst also keeps his Outperform rating on the shares, claiming that the price offers a "significant multiple discount to peers" which should become "more apparent when the midstream separation occurs" starting this week. Hanold contends that EQT will have a muted two years before its capital efficiency will take over in 2021.
11/14/18
MSCO
11/14/18
DOWNGRADE
MSCO
Underweight
EQT Corporation downgraded to Underweight from Equal Weight at Morgan Stanley
11/14/18
11/14/18
NO CHANGE

Overweight
Morgan Stanley reiterates Overweight ratings on EQT Midstream, EQGP Holdings
Morgan Stanley analyst Tom Abrams noted that his colleague Drew Venker downgraded EQT Corporation (EQT) to Underweight from Equal Weight, citing his expectations for lower-than-guidance volume and free cash flow, as previously reported. Abrams believes Venker's downgrade of EQT could weigh somewhat on EQT Midstream Partners (EQM) and EQGP Holdings (EQGP), but he reiterates his Overweight ratings on both, citing his optimism on their projects, simplification and new business. Abrams, however, trimmed his price target on EQT Midstream to $54 from $55 and slightly lowered his price target on EQGP to $23 from $24.
HAL Halliburton
$32.46

0.02 (0.06%)

10/23/18
BMOC
10/23/18
NO CHANGE
Target $50
BMOC
Outperform
Halliburton price target lowered to $50 from $54 at BMO Capital
BMO Capital analyst Daniel Boyd lowers his price target on Halliburton to $50 after the company guided Q4 earnings up to 24% below expectations to reflect the slowdown in the expected U.S. frac activity. The analyst notes that "investors are rightfully concerned by how quickly the frac market deteriorated and the slow international recovery" facing margin pressure. Boyd also states that Halliburton shares are down 33% from year-to-date highs, recommending that investors buy the dips before the market focus shift to the company's earnings power. The analyst keeps his Outperform rating on the shares.
10/23/18
RBCM
10/23/18
NO CHANGE
Target $56
RBCM
Outperform
Halliburton price target lowered to $56 from $60 at RBC Capital
RBC Capital analyst Kurt Hallead lowered his price target on Halliburton to $56 to reflect the U.S. frac market headwinds anticipated over the next 3 to 6 months. The analyst keeps his Outperform rating longer term however, stating that the company is "very well positioned to benefit from the resumption in US frac activity" and some improvement in its international market. Hallead also expects Halliburton to prioritize dividend and buybacks over debt reduction.
10/23/18
UBSW
10/23/18
NO CHANGE
Target $50
UBSW
Buy
Halliburton price target lowered to $50 from $60 at UBS
UBS analyst Sasha Sanwal lowered his price target on Halliburton to $50 from $60 following its worse than expected Q4 guidance. The analyst was surprised by the sequential decline in guidance in the North American market, but noted its International market appears more promising. Given the uncertainty around the North American market, the analyst lowered his estimates and price target. Sanwal maintained her Buy rating on Halliburton shares, but said he would wait for more clarity on the North American recovery before taking advantage of the near-term softness in the shares.
10/23/18
FBCO
10/23/18
NO CHANGE
Target $46
FBCO
Outperform
Halliburton price target lowered to $46 from $51 at Credit Suisse
Credit Suisse analyst James Wicklund lowered his price target for Halliburton to $46 from $51 following quarterly results. The analyst notes that investor concern about margin potential of its NAM completions business appears to be the critical concern. He reiterates an Outperform rating on the shares.
SLB Schlumberger
$48.24

0.17 (0.35%)

10/17/18
BOFA
10/17/18
INITIATION
Target $73
BOFA
Buy
Schlumberger initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Chase Mulvehill initiated Schlumberger with a Buy rating and a price target of $73.
10/17/18
BOFA
10/17/18
NO CHANGE
BOFA
BofA/Merrill reinstating Oilfield Services coverage with Halliburton as top pick
BofA analyst Chase Mulvehill reinstated coverage of U.S. onshore and diversified oilfield service, or OFS, saying he has a bullish near-to-medium term view on the sector. The analyst notes that OFS should outperform thanks to rising oil prices that should lead to "solid" cash flows across the sector. Mulvehill further anticipates investment to increase across the industry, with North America land E&P spending surprising to the upside and U.S. onshore D&C spending rising nearly 20%. The analyst also sees "Permian pipeline relief" adding to the benefits with exposure to the basin. Mulvehill's Top Pick is Halliburton (HAL), and his other Buy-rated names include Baker Hughes (BHGE), C&J Energy Services (CJ), FTS International (FTSI), Keane Group (FRAC), Nabors Industries (NBR), Nine Energy Service (NINE), Patterson-UTI Energy (PTEN), ProPetro Holdings Corp (PUMP), and Schlumberger (SLB).
10/22/18
FBCO
10/22/18
NO CHANGE
Target $71
FBCO
Outperform
Schlumberger price target lowered to $71 from $82 at Credit Suisse
Credit Suisse analyst Jim Wicklund lowered his price target for Schlumberger to $71 from $82 following quarterly results. The analyst reiterates an Outperform rating on the shares.
10/12/18
SPHN
10/12/18
INITIATION
Target $65
SPHN
Equal Weight
Schlumberger initiated with an Equal Weight at Stephens
Stephens analyst Tommy Moll initiated Schlumberger with an Equal Weight rating and $65 price target, stating that while he anticipates revenue growth both internationally and in North America in 2019, overly optimistic international expectations and the potential drag from North America on profitability put 2019 earnings at risk.

TODAY'S FREE FLY STORIES

ANTM

Anthem

$275.59

-4.93 (-1.76%)

, CNC

Centene

$127.55

-5.3 (-3.99%)

13:16
12/16/18
12/16
13:16
12/16/18
13:16
Periodicals
Health stocks preparing for market jolt after Obamacare ruling, Bloomberg says »

U.S. health-care stocks…

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

HUM

Humana

$300.41

-12.09 (-3.87%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

HNT

Health Net

$0.00

(0.00%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

12:35
12/16/18
12/16
12:35
12/16/18
12:35
Hot Stocks
Jeld-Wen ordered to divest Pennsylvania plant to restore competition »

Federal Judge Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/16/18
12/16
04:55
12/16/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

, GOV

Government Properties

$7.68

-0.41 (-5.07%)

17:08
12/15/18
12/15
17:08
12/15/18
17:08
Conference/Events
Select Income REIT to host special shareholder meeting »

Special Shareholder…

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

GOV

Government Properties

$7.68

-0.41 (-5.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

GOV

Government Properties

$7.68

-0.41 (-5.07%)

, SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

17:06
12/15/18
12/15
17:06
12/15/18
17:06
Conference/Events
Government Properties to host special shareholder meeting »

Special Shareholder…

GOV

Government Properties

$7.68

-0.41 (-5.07%)

SIR

Select Income REIT

$17.72

-0.52 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

12:37
12/15/18
12/15
12:37
12/15/18
12:37
Periodicals
U.S. stocks could rally about 10% in 2019, Barron's says »

As U.S. stocks stumble…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

, ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

12:21
12/15/18
12/15
12:21
12/15/18
12:21
Periodicals
Alphabet, Apple among top stock picks for 2019, Barron's says »

Even if investors have…

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

DDAIF

Daimler AG

$0.00

(0.00%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

BAC

Bank of America

$24.49

0.1 (0.41%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 12

    Feb

  • 03

    Mar

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

08:26
12/15/18
12/15
08:26
12/15/18
08:26
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

F

Ford

$8.53

0.025 (0.29%)

GM

General Motors

$35.10

-0.01 (-0.03%)

HMC

Honda

$26.90

-0.33 (-1.21%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$120.06

-0.83 (-0.69%)

VLKAY

Volkswagen

$0.00

(0.00%)

TSLA

Tesla

$365.69

-11.17 (-2.96%)

LITE

Lumentum

$43.46

-0.4 (-0.91%)

OCLR

Oclaro

$8.27

(0.00%)

FNSR

Finisar

$21.74

-0.4 (-1.81%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

INFN

Infinera

$4.14

-0.095 (-2.25%)

CIEN

Ciena

$34.55

-0.35 (-1.00%)

GOOS

Canada Goose

$52.18

-2.48 (-4.54%)

FDX

FedEx

$184.08

-3.13 (-1.67%)

UPS

UPS

$98.67

-2.1 (-2.08%)

AMZN

Amazon.com

$1,592.14

-67.86 (-4.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 07

    Jan

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/15/18
12/15
04:55
12/15/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

  • 12

    Dec

  • 12

    Dec

TEVA

Teva

$18.46

-0.56 (-2.94%)

18:34
12/14/18
12/14
18:34
12/14/18
18:34
Hot Stocks
Teva, Celltrion announce FDA approval of HERZUMA »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$7.43

(0.00%)

18:11
12/14/18
12/14
18:11
12/14/18
18:11
Hot Stocks
Pretium Resources: Brucejack approved for production hike to 3,800 tonnes/day »

Pretium Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

17:52
12/14/18
12/14
17:52
12/14/18
17:52
Periodicals
FCA says four U.S. plants to have down-time in January, Detroit News says »

Fiat Chrysler said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

, CCNI

Command Center

$4.00

-0.075 (-1.84%)

17:43
12/14/18
12/14
17:43
12/14/18
17:43
Hot Stocks
Sonoma Pharmaceuticals CEO Jim Schutz resigns, Frederick Sandford succeeds »

Sonoma Pharmaceuticals…

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

CCNI

Command Center

$4.00

-0.075 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

, XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

17:38
12/14/18
12/14
17:38
12/14/18
17:38
General news
Week ending ETF scorecard: Energy, Financials lead the decline »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

IYR

DJ US Real Estate Index Fund

$80.37

-0.14 (-0.17%)

XLP

Consumer Staples Sector SPDR

$54.51

-0.97 (-1.75%)

XLY

Consumer Discretionary Sector SPDR

$102.33

-1.75 (-1.68%)

XLB

S&P Select Materials SPDR

$51.37

-0.37 (-0.72%)

XLF

Financial Select Sector

$24.25

-0.24 (-0.98%)

XLV

Health Care Select Sector SPDR

$88.99

-3.05 (-3.31%)

XLK

Technology Select Sector SPDR

$64.58

-1.6 (-2.42%)

XLI

Industrial Select Sector SPDR

$67.06

-0.95 (-1.40%)

GLD

SPDR Gold Shares

$117.10

-0.44 (-0.37%)

SLV

iShares Silver Trust

$13.69

-0.175 (-1.26%)

USO

United States Oil Fund

$10.83

-0.38 (-3.39%)

UNG

United States Natural Gas Fund

$30.78

-2.64 (-7.90%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.17

-0.365 (-0.44%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.72

-0.125 (-0.11%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

0.38 (0.32%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.57

0.19 (0.19%)

SHY

iShares 1-3 Year Treasury Bond

$83.31

0.055 (0.07%)

IWD

iShares Russell 1000 Value

$116.15

-1.71 (-1.45%)

IWF

iShares Russell 1000 Growth

$135.70

-2.96 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEI

Ecology & Environment

$11.50

0.2 (1.77%)

17:35
12/14/18
12/14
17:35
12/14/18
17:35
Hot Stocks
Ecology & Environment receives Nasdaq noncompliance notice »

On December 13, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$8.96

-0.045 (-0.50%)

17:34
12/14/18
12/14
17:34
12/14/18
17:34
Hot Stocks
Luther Burbank announces systematic share repurchase plan »

Luther Burbank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.33

0.01 (0.76%)

17:31
12/14/18
12/14
17:31
12/14/18
17:31
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLGT

Radiant Logistics

$4.76

-0.06 (-1.24%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on Radiant Logistics »

Radiant Logistics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$22.62

-1.39 (-5.79%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on KalVista »

KalVista files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

17:25
12/14/18
12/14
17:25
12/14/18
17:25
Hot Stocks
POTUS names Mick Mulvaney acting WH chief of staff »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$169.87

-2.585 (-1.50%)

17:20
12/14/18
12/14
17:20
12/14/18
17:20
Hot Stocks
Raytheon awarded $149.44M Navy contract for Standard Missile-2 Block IIIC »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$100.08

-2.73 (-2.66%)

17:15
12/14/18
12/14
17:15
12/14/18
17:15
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.